Categorynews

Global Injectable Drug Delivery Devices Market 2022-2026: Digitalization of Healthcare Sector Driving Growth – ResearchAndMarkets.com

November 17, 2022 Off By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Injectable Drug Delivery Devices Market 2022-2026” report has been added to ResearchAndMarkets.com’s offering.

The injectable drug delivery devices market is poised to grow by $22.29 bn during 2022-2026, progressing at a CAGR of 8.48% during the forecast period. The report on the injectable drug delivery devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of chronic diseases and growth in the biologics market.

The injectable drug delivery devices market analysis includes the type segment and geographic landscape.

The injectable drug delivery devices market is segmented as below:

By Type

  • Advanced injectable drug delivery devices
  • Conventional injectable drug delivery devices

By Geography

  • North America
  • Europe
  • Asia
  • ROW

This study identifies digitalization in the healthcare system as one of the prime reasons driving the injectable drug delivery devices market growth during the next few years.

The report on injectable drug delivery devices market covers the following areas:

  • Injectable drug delivery devices market sizing
  • Injectable drug delivery devices market forecast
  • Injectable drug delivery devices market industry analysis

Key Topics Covered:

Executive Summary

Market Landscape

Market Sizing

Five Forces Analysis

Market Segmentation by Type

Customer landscape

Geographic Landscape

Drivers, Challenges, and Trends

Vendor Landscape

Vendor Analysis

Appendix

Companies Mentioned

  • AstraZeneca Plc
  • Baxter International Inc.
  • Becton Dickinson and Co.
  • Eli Lilly and Co.
  • Gerresheimer AG
  • Owen Mumford Ltd.
  • Sanofi SA
  • SCHOTT AG
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

For more information about this report visit https://www.researchandmarkets.com/r/relxr2

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900